Huadong Medicine Co Ltd Capital Reinvestment Ratio
Huadong Medicine Co Ltd capital reinvestment ratio. Huadong Medicine Co Ltd (000963) has a Capital Reinvestment Ratio of 1.90x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥155.98 Million) in capital expenditures (CN¥297.09 Million). See 000963 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Huadong Medicine Co Ltd (1998–2024)
Capital reinvestment ratio of Huadong Medicine Co Ltd from 1998 to 2024. This chart tracks Huadong Medicine Co Ltd's Capital Reinvestment Ratio across 26 annual periods. See financial agility of Huadong Medicine Co Ltd to measure the company's free cash flow as a share of total liabilities.
Huadong Medicine Co Ltd Capital Reinvestment Ratio by Year (1998–2024)
Huadong Medicine Co Ltd capital reinvestment ratio by year from 1998 to 2024. For the full cash flow conversion analysis, see 000963 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.46x | CN¥3.75 Billion | CN¥1.73 Billion | ▲ +12.7% |
| 2023 | 0.41x | CN¥3.93 Billion | CN¥1.61 Billion | ▼ -18.4% |
| 2022 | 0.50x | CN¥2.38 Billion | CN¥1.19 Billion | ▲ +93.9% |
| 2021 | 0.26x | CN¥3.17 Billion | CN¥819.10 Million | ▼ -40.2% |
| 2020 | 0.43x | CN¥3.41 Billion | CN¥1.47 Billion | ▼ -36.1% |
| 2019 | 0.68x | CN¥2.00 Billion | CN¥1.35 Billion | ▲ +57.3% |
| 2018 | 0.43x | CN¥2.04 Billion | CN¥876.46 Million | ▲ +49.1% |
| 2017 | 0.29x | CN¥1.66 Billion | CN¥478.69 Million | ▼ -16.9% |
| 2016 | 0.35x | CN¥1.35 Billion | CN¥467.00 Million | ▼ -40.4% |
| 2015 | 0.58x | CN¥658.54 Million | CN¥383.01 Million | ▲ +32.6% |
| 2014 | 0.44x | CN¥740.85 Million | CN¥324.89 Million | ▼ -37.7% |
| 2013 | 0.70x | CN¥476.98 Million | CN¥335.84 Million | ▲ +76.1% |
| 2012 | 0.40x | CN¥642.73 Million | CN¥256.97 Million | ▼ -97.1% |
| 2011 | 13.91x | CN¥16.12 Million | CN¥224.21 Million | ▲ +6009.9% |
| 2009 | 0.23x | CN¥567.94 Million | CN¥129.26 Million | ▼ -11.1% |
| 2008 | 0.26x | CN¥344.69 Million | CN¥88.24 Million | ▲ +110.8% |
| 2007 | 0.12x | CN¥265.79 Million | CN¥32.27 Million | ▼ -91.7% |
| 2006 | 1.46x | CN¥57.38 Million | CN¥83.53 Million | ▲ +492.0% |
| 2005 | 0.25x | CN¥203.33 Million | CN¥50.00 Million | ▼ -95.4% |
| 2004 | 5.33x | CN¥12.51 Million | CN¥66.60 Million | ▲ +558.2% |
| 2003 | 0.81x | CN¥90.54 Million | CN¥73.24 Million | ▼ -65.7% |
| 2002 | 2.36x | CN¥23.94 Million | CN¥56.47 Million | ▲ +386.1% |
| 2001 | 0.49x | CN¥109.67 Million | CN¥53.21 Million | ▼ -85.6% |
| 2000 | 3.37x | CN¥19.59 Million | CN¥66.01 Million | ▲ +1565.3% |
| 1999 | 0.20x | CN¥56.32 Million | CN¥11.40 Million | ▼ -62.1% |
| 1998 | 0.53x | CN¥23.80 Million | CN¥12.70 Million | — |